Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 3
1995 6
1996 2
1997 2
1998 3
1999 2
2000 1
2001 1
2003 2
2004 2
2005 3
2006 3
2007 6
2008 1
2009 1
2010 2
2011 1
2012 4
2013 6
2014 1
2015 3
2016 2
2017 1
2018 1
2019 3
2020 1
2021 2
2022 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

61 results

Results by year

Filters applied: . Clear all
Page 1
Von Hippel-Lindau disease.
Chittiboina P, Lonser RR. Chittiboina P, et al. Handb Clin Neurol. 2015;132:139-56. doi: 10.1016/B978-0-444-62702-5.00010-X. Handb Clin Neurol. 2015. PMID: 26564077 Free PMC article. Review.
Individuals with VHL develop benign and malignant tumors including retinal and central nervous system hemangioblastomas, clear cell renal cell carcinomas (RCC), pheochromocytomas, pancreatic neuroendocrine tumors and endolymphatic sac tumors (ELSTs). ...
Individuals with VHL develop benign and malignant tumors including retinal and central nervous system hemangioblastomas, clear cell r …
von Hippel-Lindau syndrome.
Chou A, Toon C, Pickett J, Gill AJ. Chou A, et al. Front Horm Res. 2013;41:30-49. doi: 10.1159/000345668. Epub 2013 Mar 19. Front Horm Res. 2013. PMID: 23652669 Review.
Type 1 VHL is predominantly associated with large deletion or truncation mutations which result in an encoded protein with very little or no activity. It is associated with retinal and CNS hemangioblastoma and renal cell carcinoma but not pheochromocytoma. ...
Type 1 VHL is predominantly associated with large deletion or truncation mutations which result in an encoded protein with very little or no …
von Hippel-Lindau disease.
Singh AD, Shields CL, Shields JA. Singh AD, et al. Surv Ophthalmol. 2001 Sep-Oct;46(2):117-42. doi: 10.1016/s0039-6257(01)00245-4. Surv Ophthalmol. 2001. PMID: 11578646 Review.
The inheritance of VHL disease is autosomal dominant with high penetrance. Depending on the clinical circumstances, retinal capillary hemangioma may be managed by observation, laser photocoagulation, cryotherapy, and plaque radiotherapy. ...We review herein t …
The inheritance of VHL disease is autosomal dominant with high penetrance. Depending on the clinical circumstances, retinal capill
Optic Nerve Hemangioblastoma: Review.
Darbari S, Meena RK, Sawarkar D, Doddamani RS. Darbari S, et al. World Neurosurg. 2019 Aug;128:211-215. doi: 10.1016/j.wneu.2019.04.224. Epub 2019 May 1. World Neurosurg. 2019. PMID: 31054346 Review.
Color discrimination was impaired. Fundoscopy revealed optic atrophy and no other retinal pathology. There was relative afferent pupillary defect in the right eye. ...
Color discrimination was impaired. Fundoscopy revealed optic atrophy and no other retinal pathology. There was relative afferent pupi …
Retinal vasoproliferative tumor.
Marback EF, Guerra RL, Maia Junior Ode O, Marback RL. Marback EF, et al. Arq Bras Oftalmol. 2013 May-Jun;76(3):200-3. doi: 10.1590/s0004-27492013000300016. Arq Bras Oftalmol. 2013. PMID: 23929086 Free article. Review.
Retinal vasoproliferative tumor is a rare disease that has capillary hemangioma as the most frequent diferential diagnosis. ...It can be idiophatic or secondary to other ocular diseases such as: uveitis, retinitis pigmentosa, sickle cell disease, previ
Retinal vasoproliferative tumor is a rare disease that has capillary hemangioma as the most frequent diferential diagno
Intravitreal bevacizumab for retinal capillary hemangioblastoma: A case series and literature review.
Slim E, Antoun J, Kourie HR, Schakkal A, Cherfan G. Slim E, et al. Can J Ophthalmol. 2014 Oct;49(5):450-7. doi: 10.1016/j.jcjo.2014.07.007. Can J Ophthalmol. 2014. PMID: 25284102 Review.
OBJECTIVE: To evaluate the long-term outcomes of intravitreal bevacizumab for peripheral and juxtapapillary retinal capillary hemangioblastoma (RCH). DESIGN: We conducted a retrospective noncomparative interventional case series. ...The fellow eye with fibrotic band …
OBJECTIVE: To evaluate the long-term outcomes of intravitreal bevacizumab for peripheral and juxtapapillary retinal capillary
VHL disease.
Barontini M, Dahia PL. Barontini M, et al. Best Pract Res Clin Endocrinol Metab. 2010 Jun;24(3):401-13. doi: 10.1016/j.beem.2010.01.002. Best Pract Res Clin Endocrinol Metab. 2010. PMID: 20833332 Review.
von Hippel-Lindau disease (VHL) disease increases susceptibility to several malignancies, including renal cell carcinoma, haemangioblastomas of the central nervous system or retina and phaeochromocytomas. The VHL tumour suppressor gene, responsible for the disease, encodes …
von Hippel-Lindau disease (VHL) disease increases susceptibility to several malignancies, including renal cell carcinoma, haemangioblastomas …
MANAGEMENT OF RETINAL HEMANGIOBLASTOMA IN VON HIPPEL-LINDAU DISEASE.
Wiley HE, Krivosic V, Gaudric A, Gorin MB, Shields C, Shields J, Aronow ME, Chew EY. Wiley HE, et al. Retina. 2019 Dec;39(12):2254-2263. doi: 10.1097/IAE.0000000000002572. Retina. 2019. PMID: 31259811 Free PMC article. Review.
PURPOSE: To review the current state of diagnosis and management of retinal hemangioblastoma and retinal vascular proliferation arising from von Hippel-Lindau (VHL) disease. ...There was consensus on core principles, including 1) recognition and diagnosis of von Hip …
PURPOSE: To review the current state of diagnosis and management of retinal hemangioblastoma and retinal vascular proliferatio …
Current concepts on ocular vascular abnormalities in the phakomatoses.
de Paula A, Abdolrahimzadeh S, Fragiotta S, Di Pippo M, Scuderi G. de Paula A, et al. Semin Ophthalmol. 2021 Oct 3;36(7):549-560. doi: 10.1080/08820538.2021.1900284. Epub 2021 Mar 23. Semin Ophthalmol. 2021. PMID: 33755531 Review.
They are characterized by ocular vascular abnormalities such as vascular tortuosity, corkscrew retinal vessel configuration, moyamoya-like aspect, microaneurysms, hemangioblastomas, and focal sheathing of retinal arteries, possibly due to abnormal formation, migrati …
They are characterized by ocular vascular abnormalities such as vascular tortuosity, corkscrew retinal vessel configuration, moyamoya …
von Hippel-Lindau disease.
Couch V, Lindor NM, Karnes PS, Michels VV. Couch V, et al. Mayo Clin Proc. 2000 Mar;75(3):265-72. doi: 10.4065/75.3.265. Mayo Clin Proc. 2000. PMID: 10725953 Review.
An autosomal dominant tumor predisposition syndrome, von Hippel-Lindau disease (VHL) is characterized by the presence of benign and malignant tumors. Hallmark lesions include retinal angiomas, hemangioblastomas of the cerebellum and spinal cord, and renal cell carcinomas. …
An autosomal dominant tumor predisposition syndrome, von Hippel-Lindau disease (VHL) is characterized by the presence of benign and malignan …
61 results